Literature DB >> 12226805

Strategies to control antibiotic resistance.

Burke A Cunha1.   

Abstract

Antibiotic resistance is becoming a worldwide concern. Antibiotic resistance may be caused by sporadic mutations, which are not important unless spread clonally. Clonal resistance may disseminate a highly resistant clone to widespread geographic areas. The most effective interventions to limit the clonal spread of resistant organisms are effective infection control measures. Hospital antibiotic formulary restriction is the only control measure with proven effectiveness to control resistance related to antibiotic use. Hospital formularies should eliminate or restrict antibiotics with a high-resistance potential (eg, ceftazidime, ciprofloxacin, and imipenem), and should be replaced with equivalent antibiotics with a low-resistance potential (eg, cefe-pime, levofloxacin, and meropenem). Such low-resistance-potential antibiotics can either prevent or eliminate resistance problems associated with Klebsiella pneumoniae, Enterobacter species, or Pseudomonas aeruginosa. High-resistance-potential antibiotics, particularly ciprofloxacin and ceftazidime, also may indirectly increase the prevalence of highly resistant organisms (eg, methicillin-resistant Staphylococcus aureus [MRSA], vancomycin-resistant enterococci [VRE]). Vancomycin use should be restricted, not because it increases enterococcal resistance per se, but because it selects out naturally resistant enterococcal strains (eg, Enterococcus faecium that are vancomycin resistant). Linezolid does not increase the prevalence of VRE. Clinicians in the outpatient setting should also preferentially use oral antibiotics with a low-resistance potential (eg, clindamycin, metronidazole, doxycycline, minocycline, fluoroquinolones except ciprofloxacin, linezolid, and oral cephalosporins) in preference to their high-resistance-potential counterparts. For antibiotic resistance control interventions to be effective, they must be applied simultaneously to all antibiotics with activity against the specific resistance pathogen at the hospital formulary level. Multiple antibiotic substitutions are usually necessary to eradicate resistance problems caused by a particular pathogen. Multiple drugs of the same spectrum and low-resistance potential are necessary to eliminate resistance problems; single antibiotic substitutions are not effective. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12226805     DOI: 10.1053/srin.2002.34692

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  9 in total

1.  Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: an idea whose time has come.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-15       Impact factor: 3.267

2.  Evaluation of the introduction of an antimicrobial drugs formulary in a general hospital in Slovenia.

Authors:  Jure Peklar; Franci Tratar; Ales Mrhar
Journal:  Pharm World Sci       Date:  2004-12

3.  The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus.

Authors:  Que Chi Truong-Bolduc; David C Hooper
Journal:  J Bacteriol       Date:  2007-02-02       Impact factor: 3.490

4.  Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs.

Authors:  Styliani Karanika; Suresh Paudel; Christos Grigoras; Alireza Kalbasi; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

5.  Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria.

Authors:  Harry G Preuss; Bobby Echard; Mary Enig; Itzhak Brook; Thomas B Elliott
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

6.  Phosphorylation of MgrA and its effect on expression of the NorA and NorB efflux pumps of Staphylococcus aureus.

Authors:  Que Chi Truong-Bolduc; David C Hooper
Journal:  J Bacteriol       Date:  2010-03-16       Impact factor: 3.490

Review 7.  Ventilator-associated pneumonia: monotherapy is optimal if chosen wisely.

Authors:  Burke A Cunha
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

8.  A brief multi-disciplinary review on antimicrobial resistance in medicine and its linkage to the global environmental microbiota.

Authors:  L Cantas; Syed Q A Shah; L M Cavaco; C M Manaia; F Walsh; M Popowska; H Garelick; H Bürgmann; H Sørum
Journal:  Front Microbiol       Date:  2013-05-14       Impact factor: 5.640

9.  Staphylococcus aureus and Escherichia hermanii in diabetes patient.

Authors:  Gabriel Adrian Popescu; Ioana Daha; Cristina Popescu; Elena Mitache
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.